Shares of STERIS plc (NYSE: STE - Get Free Report) have earned an average rating of "Moderate Buy" from the nine ratings firms that are currently covering the firm, Marketbeat.com reports. Two investm
Copeland Capital Management LLC cut its position in shares of STERIS plc (NYSE: STE) by 4.4% in the undefined quarter, according to the company in its most recent disclosure with the SEC. The fund own
Carnegie Investment Counsel reduced its position in shares of STERIS plc (NYSE: STE) by 6.2% in the third quarter, according to its most recent filing with the SEC. The fund owned 53,192 shares of the

What Makes Steris (STE) a New Buy Stock

01:01pm, Friday, 26'th Dec 2025
Steris (STE) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Addenda Capital Inc. acquired a new stake in STERIS plc (NYSE: STE) in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional in
Sotera Health, a sterilization solutions provider, is gaining investor attention due to easing litigation and improving cash flow.
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

STERIS plc $STE Shares Purchased by Axa S.A.

04:26am, Friday, 12'th Dec 2025
Axa S.A. raised its holdings in shares of STERIS plc (NYSE: STE) by 26.3% in the undefined quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institution
Steris (STE) reported earnings 30 days ago. What's next for the stock?
STE posts solid AST and Healthcare growth, but currency swings and macro pressures pose rising challenges.
Groupe la Francaise boosted its position in shares of STERIS plc (NYSE: STE) by 19.5% during the second quarter, according to the company in its most recent Form 13F filing with the SEC. The instituti
STERIS (NYSE: STE - Get Free Report) and iRadimed (NASDAQ: IRMD - Get Free Report) are both medical companies, but which is the better business? We will compare the two businesses based on the strengt

Steris (STE) Upgraded to Buy: Here's Why

01:01pm, Thursday, 20'th Nov 2025
Steris (STE) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Examine the evolution of Steris' (STE) overseas revenue trends and their effects on Wall Street's forecasts and the stock's prospects.
Total Revenue Growth: 10% as-reported revenue growth in Q2.Constant Currency Organic Revenue Growth: 9% in Q2.Gross Margin: Increased 60 basis points to 44.3%.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE